SIGN OUR PHYSICIAN LETTER TO FDA: SAVE COMPOUNDED HORMONE THERAPY!
By now you’ve heard that the FDA has signaled it may restrict compounded hormone therapy based on a discredited report it commissioned – a report marred by bias, manipulation, limited scope, and a lack of scientific rigor.
Maybe you also know that we have created an informational website, compounding.com, where patients and prescribers can share their compounded hormone testimonials with members of Congress and urge elected officials to slow FDA down on its wrong-headed effort to restrict hormone compounding.
But did you know that members of Congress – and U.S. Senators in particular – are telling us they’re not hearing much concern from physicians and other prescribers about this threat? One senator told APC recently that she’d heard from a great number of pharmacists, but very few physicians, and that made her question whether the threat to patients was a real concern.
To address this perceived lack of interest among physicians, APC has drafted a cBHT prescriber letter to FDA Commissioner Robert Califf (with copies to go to congressional leaders) urging the commissioner to slow down, to base any decision about compounded hormones on solid evidence, and to avoid any action that might impede patient access to life-enhancing compounded hormones.
If you are a prescriber of compounded hormones, we invite you to review the letter and add your name to it.
HERE IS THE DRAFT LETTER FOR YOUR REVIEW.
ADD YOUR NAME TO THE LETTER HERE.
The deadline for adding your name to the Califf letter has been extended to Wednesday, August 17, 2022, so act now: Do your part to preserve your patients’ access to compounded hormone therapy.